Herantis Pharma Oyj (HEL: HRTIS)

Market Cap	32.26M
Revenue (ttm)	n/a
Net Income (ttm)	-612.16K
Shares Out	20.16M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,258
Average Volume	18,218
Open	1.645
Previous Close	1.630
Day's Range	1.610 - 1.655
52-Week Range	1.170 - 1.880
Beta	0.30
RSI	53.58
Earnings Date	Mar 6, 2025

About Herantis Pharma Oyj

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson’s disease (PD). Its lead product in pipeline includes HER-096, an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein for the treatment of PD and other neurodegenerative diseases. The company was incorporated in 2008 and is based in Espoo, Finland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 10
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: HRTIS